£47.00

LAP Lambert Academic Publishing Angiotensin Receptor Blockers & ACE Inhibitors: Role as Anti-inflammatory Agents

Price data last checked 103 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£47 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 628 days • 628 data points (No recent data available)

Historical
Generating forecast...
£47.00 £44.65 £45.59 £46.53 £47.47 £48.41 £49.35 09 June 2024 12 November 2024 18 April 2025 22 September 2025 26 February 2026

Price Distribution

Price distribution over 628 days • 1 price levels

Days at Price
628 days 0 157 314 471 628 £47 Days at Price

Price Analysis

Most common price: £47 (628 days, 100.0%)

Price range: £47 - £47

Price levels: 1 different prices over 628 days

Description

Angiotensin receptor blockers (ARBs) and angiotensin converting enzyme (ACE) inhibitors are drugs which are widely being prescribed for patients of hypertension, myocardial infarction, congestive cardiac failure, etc. These ailments are commonly found in older adults in whom, other conditions like atherosclerosis, etc., which have a potential inflammatory component in their etiopathogenesis, usually coexist. As a result, there has been an increasing interest in research showing effects of these compounds on inflammation. Although there have been several relevant studies in the past, there are conflicting and inconclusive reports on the same. In this book, we therefore attempt to evaluate the effect of ARBs and ACE inhibitors in an experimental model of acute inflammation in rats. The well-established carrageenan-induced paw edema model of acute inflammation has been used for this study. This book covers commonly prescribed ARBs and ACE inhibitors in practice as regards their effects on inflammation, and therefore will especially add to the knowledge of students, researchers as well as clinicians in the therapeutics of ARBs and ACE inhibitors.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
08 December 2013
Listed Since
10 December 2013

Barcode

No barcode data available

Similar Products You Might Like

ACE Inhibitors (Milestones in Drug Therapy)
96% match

ACE Inhibitors (Milestones in Drug Therapy)

Birkhauser

£41.58 15 Feb 2026
ACE Inhibitors: Medical Uses and Mechanisms - Volume 1
96% match

ACE Inhibitors: Medical Uses and Mechanisms - Volume 1

£90.12 20 Feb 2026
ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects & Related Topics -- Volume 2
96% match

ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects & Related Topics -- Volume 2

Nova Science Publishers Inc

£39.44 22 Jan 2026
ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects & Related Topics -- Volume 1
96% match

ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects & Related Topics -- Volume 1

Nova Science Publishers Inc

£42.93 17 Feb 2026
Angiotensin II - Antagonismus: Ein neuer Weg zur Hochdruckbehandlung
96% match

Angiotensin II - Antagonismus: Ein neuer Weg zur Hochdruckbehandlung

Springer

£46.99 07 Mar 2026
Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology)
96% match

Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology)

Springer

£227.64 08 Apr 2026
Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology, 2)
95% match

Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology, 2)

Springer

£246.73 09 Dec 2025
Springer - Angiotensin Receptors: Cellular and Molecular Aspects
95% match

Springer - Angiotensin Receptors: Cellular and Molecular Aspects

Springer

£113.77 19 Apr 2026
Angiotensin-Converting Enzyme: Functions and Role in Disease (Biochemistry Research Trends)
95% match

Angiotensin-Converting Enzyme: Functions and Role in Disease (Biochemistry Research Trends)

£203.99 24 Feb 2026
Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors: 396 (Advances in Experimental Medicine and Biology, 396)
95% match

Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors: 396 (Advances in Experimental Medicine and Biology, 396)

Springer

£119.89 18 Apr 2026
Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases
94% match

Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases

Springer

£107.47 07 Mar 2026
Renin Angiotensin System and Cardiovascular Disease (Contemporary Cardiology)
94% match

Renin Angiotensin System and Cardiovascular Disease (Contemporary Cardiology)

Humana

£79.93 29 Jan 2026
Congestive Heart Failure: Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania: 75 (Developments in Cardiovascular Medicine, 75)
94% match

Congestive Heart Failure: Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania: 75 (Developments in Cardiovascular Medicine, 75)

Springer

£169.49 11 Mar 2026
New Targets for the Treatment of Hypertension and Associated Diseases: Volume 94 (Advances in Pharmacology, Volume 94)
94% match

New Targets for the Treatment of Hypertension and Associated Diseases: Volume 94 (Advances in Pharmacology, Volume 94)

Academic Press

£150.59 16 Feb 2026
Angiotensin Vol. II: 163 / 2 (Handbook of Experimental Pharmacology, 163 / 2)
94% match

Angiotensin Vol. II: 163 / 2 (Handbook of Experimental Pharmacology, 163 / 2)

Springer

£212.89 14 Feb 2026
Comprehensive Management of High Risk Cardiovascular Patients: 57 (Fundamental and Clinical Cardiology)
94% match

Comprehensive Management of High Risk Cardiovascular Patients: 57 (Fundamental and Clinical Cardiology)

CRC Press

£52.16 01 Mar 2026
Angiotensin Vol. I: 163 / 1 (Handbook of Experimental Pharmacology, 163 / 1)
94% match

Angiotensin Vol. I: 163 / 1 (Handbook of Experimental Pharmacology, 163 / 1)

Springer

£149.50 21 Feb 2026
The Protective Arm of the Renin Angiotensin System (RAS): Functional Aspects and Therapeutic Implications
94% match

The Protective Arm of the Renin Angiotensin System (RAS): Functional Aspects and Therapeutic Implications

Academic Press

£84.97 15 Apr 2026
Molecular Basis for Microcirculatory Disorders
94% match

Molecular Basis for Microcirculatory Disorders

Springer

£22.36 08 Mar 2026
Molecular Basis for Microcirculatory Disorders
94% match

Molecular Basis for Microcirculatory Disorders

Springer

£78.84 01 Mar 2026
Angiotensin Vol. II: 163 / 2 (Handbook of Experimental Pharmacology, 163 / 2)
94% match

Angiotensin Vol. II: 163 / 2 (Handbook of Experimental Pharmacology, 163 / 2)

Springer

£152.00 19 Feb 2026
Molecular Approaches to Heart Failure Therapy
94% match

Molecular Approaches to Heart Failure Therapy

Springer

£89.98 01 Mar 2026
Arterial Hypertension: Etiology, Pathophysiology and Treatment Options (Cardiology Research and Clinical Developments)
94% match

Arterial Hypertension: Etiology, Pathophysiology and Treatment Options (Cardiology Research and Clinical Developments)

£94.15 27 Feb 2026
Frontiers in Research of the Renin-Angiotensin System on Human Disease: 7 (Proteases in Biology and Disease, 7)
94% match

Frontiers in Research of the Renin-Angiotensin System on Human Disease: 7 (Proteases in Biology and Disease, 7)

Springer

£149.25 23 Feb 2026